| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jul 29, 2026 | Sell(S) | 149K | $33.32 | $4.9M | 2.6M |
| Jul 28, 2026 | Grant(A) | 222K | — | $0 | 2.7M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-324448) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Viking Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.